搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
33 分钟
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic ...
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by ...
Daily
1 小时
Sanofi, Regeneron Dupixent sBLA accepted for USFDA review for chronic spontaneous urticaria
Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the ...
13 小时
on MSN
Inevitable spread of varroa mite prompts concern for food security and prices
As the varroa mite continues to cut a destructive path across Australia, demand and prices for pollination services are set ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Tapped as energy secretary
Jake Paul defeats Mike Tyson
Gymnastics coach dies at 82
Attends UFC fight in NYC
Flash bombs target home
Biden meets with Xi
Six Flags retires Kingda Ka
USPS to release stamp
Plane struck by bullet
Japan's minister visits UKR
98th World Cup win
Retires from NFL at 27
Trump meets with Milei
Opposes RFK Jr. nomination
Court: Execution can resume
Named WH press secretary
Sentenced to life in prison
Probing hateful emails, texts
Overtime pay rule blocked
Hit by stray bullet
World Series winner dies
Flight avoids mountain
Severe mpox strain in CA
Instruments up for auction
Musk expands OpenAI suit
Opposes Gaetz report
Wrongful death lawsuit filed
Fritz reaches title match
Lays off over 400 workers
反馈